2026 Q1 Portfolio Activity
In 2026 Q1, BRAIDWELL LP maintained a portfolio of 104 distinct positions. The most significant new addition was GUARDANT HEALTH INC, now representing 1.54% of the total fund value. They heavily accumulated shares in GUARDANT HEALTH INC, increasing the position by 14.1%. The fund also reduced its exposure to GUARDANT HEALTH INC by 97.9%.
Position History
hover any row below to update
Loading…
Total Positions
104
Quarter
2026 Q1
Top Holding
CAI (4.8%)
Top 10 Concentration
30.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 104
BRAIDWELL LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 4.78% | 6.74% |
#1
Prev: #1
|
4.4 |
—
|
193,305 | 2.5% |
P
S
|
8,009,447 | $143,208,912 |
$26.52
-37.8%
|
2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
GUARDANT HEALTH...
|
|
Bond/Debt | 3.42% | 6.15% |
#2
Prev: #2
|
2.9 |
—
|
-43,900,000 | -41.9% |
P
S
|
60,954,000 | $102,575,501 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
REPLIGEN CORP
|
|
Bond/Debt | 3.29% | 3.54% |
#3
1
Prev: #4
|
3.3 |
—
|
no change | no change |
P
S
|
101,000,000 | $98,677,000 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
N/A
NEOGENOMICS INC
|
|
Bond/Debt | 3.06% | 2.87% |
#4
3
Prev: #7
|
2.7 |
—
|
no change | no change |
P
S
|
100,381,000 | $91,848,615 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
NBIX
NEUROCRINE BIOS...
|
Healthcare | 2.87% | 3.41% |
#5
Prev: #5
|
2.1 |
—
|
-99,413 | -13.2% |
P
S
|
652,121 | $85,910,421 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 2.74% | 3.33% |
#6
Prev: #6
|
1.6 |
—
|
-158,474 | -17.2% |
P
S
|
763,505 | $82,198,948 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 2.63% | 1.75% |
#7
9
Prev: #16
|
1.6 |
—
|
-201,552 | -9.2% |
P
S
|
1,986,768 | $78,914,425 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 2.60% | 2.62% |
#8
1
Prev: #9
|
1.0 |
—
|
-486,624 | -26.7% |
P
S
|
1,338,452 | $77,830,984 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.52% | 1.68% |
#9
11
Prev: #20
|
1.0 |
—
|
-374,571 | -29.4% |
P
S
|
899,364 | $75,474,627 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 2.47% | 4.14% |
#10
7
Prev: #3
|
1.0 |
—
|
-2,863,248 | -54.9% |
P
S
|
2,347,583 | $73,948,865 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IRTC
IRHYTHM HOLDING...
|
Healthcare | 2.40% | 1.23% |
#11
21
Prev: #32
|
4.0 |
—
|
392,847 | 180.7% |
P
S
|
610,192 | $72,014,860 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 2.39% | 2.64% |
#12
4
Prev: #8
|
1.5 |
—
|
-120,977 | -14.7% |
P
S
|
700,429 | $71,758,951 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 2.31% | 1.85% |
#13
1
Prev: #14
|
1.4 |
—
|
-254,123 | -12.3% |
P
S
|
1,818,665 | $69,327,510 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 2.22% | 2.48% |
#14
4
Prev: #10
|
0.9 |
—
|
-885,788 | -47.4% |
P
S
|
984,783 | $66,650,113 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
ALPHATEC HLDGS ...
|
|
Bond/Debt | 2.11% | — |
#15
Prev: #—
|
4.3 |
—
|
61,621,000 | — |
NEW
|
61,621,000 | $63,389,523 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
ARGX
ARGENX SE
|
Healthcare | 2.07% | 0.83% |
#16
31
Prev: #47
|
3.8 |
—
|
53,932 | 173.9% |
P
S
|
84,939 | $62,026,705 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 1.87% | 1.94% |
#17
5
Prev: #12
|
2.7 |
—
|
150,500 | 11.5% |
P
S
|
1,455,123 | $56,109,543 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.84% | 1.74% |
#18
Prev: #18
|
3.2 |
—
|
439,178 | 21.6% |
P
S
|
2,471,199 | $55,008,890 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 1.76% | 0.48% |
#19
39
Prev: #58
|
3.7 |
—
|
2,258,258 | 238.1% |
P
S
|
3,206,574 | $52,748,142 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KRYS
KRYSTAL BIOTECH...
|
Healthcare | 1.57% | 1.59% |
#20
4
Prev: #24
|
1.1 |
—
|
-19,676 | -9.7% |
P
S
|
182,425 | $47,124,026 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.57% | 1.71% |
#21
2
Prev: #19
|
0.6 |
—
|
-701,792 | -42.9% |
P
S
|
932,823 | $47,051,592 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 1.54% | — |
#22
Prev: #—
|
4.1 |
—
|
499,712 | — |
NEW
|
499,712 | $46,158,397 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 1.52% | 1.50% |
#23
3
Prev: #26
|
2.6 |
—
|
12,190 | 15.1% |
P
S
|
92,915 | $45,670,510 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
GENERATE BIOMED...
|
|
Unknown | 1.50% | — |
#24
Prev: #—
|
4.1 |
—
|
3,592,999 | — |
NEW
|
3,592,999 | $44,912,488 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
MBX
MBX BIOSCIENCES...
|
Healthcare | 1.49% | 1.03% |
#25
14
Prev: #39
|
3.1 |
—
|
473,867 | 46.5% |
P
S
|
1,492,467 | $44,550,140 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BTSG
BRIGHTSPRING HE...
|
Healthcare | 1.44% | 1.43% |
#26
1
Prev: #27
|
1.1 |
—
|
-179,224 | -15.0% |
P
S
|
1,016,562 | $43,315,707 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 1.43% | 1.61% |
#27
5
Prev: #22
|
0.6 |
—
|
-502,027 | -27.0% |
P
S
|
1,356,082 | $43,014,921 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NEO
NEOGENOMICS INC
|
Healthcare | 1.39% | 1.74% |
#28
11
Prev: #17
|
3.1 |
—
|
984,601 | 21.3% |
P
S
|
5,617,402 | $41,681,123 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 1.34% | 1.39% |
#29
Prev: #29
|
1.0 |
—
|
-96,400 | -16.8% |
P
S
|
478,667 | $40,289,401 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 1.31% | 0.81% |
#30
19
Prev: #49
|
3.5 |
—
|
215,350 | 66.4% |
P
S
|
539,708 | $39,382,493 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CDNA
CAREDX INC
|
Healthcare | 1.26% | 0.96% |
#31
10
Prev: #41
|
3.0 |
—
|
587,926 | 37.1% |
P
S
|
2,173,146 | $37,725,815 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.19% | 1.51% |
#32
7
Prev: #25
|
1.0 |
—
|
-6,120 | -7.3% |
P
S
|
77,297 | $35,633,144 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
INSP
INSPIRE MED SYS...
|
Healthcare | 1.17% | 1.60% |
#33
10
Prev: #23
|
3.0 |
—
|
136,680 | 25.3% |
P
S
|
677,570 | $34,949,061 | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 1.15% | 1.10% |
#34
4
Prev: #38
|
1.0 |
—
|
-4,800 | -4.4% |
P
S
|
105,352 | $34,594,436 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TMDX
TRANSMEDICS GRO...
|
Healthcare | 1.09% | 1.23% |
#35
2
Prev: #33
|
0.9 |
—
|
14,050 | 4.5% |
P
S
|
329,391 | $32,744,759 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SLNO
SOLENO THERAPEU...
|
Healthcare | 1.07% | 1.76% |
#36
21
Prev: #15
|
0.9 |
—
|
-228,600 | -19.2% |
P
S
|
959,259 | $32,115,991 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.02% | 0.92% |
#37
5
Prev: #42
|
2.4 |
—
|
203,669 | 13.8% |
P
S
|
1,681,998 | $30,494,624 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRVI
MARAVAI LIFESCI...
|
Healthcare | 0.97% | 0.87% |
#38
7
Prev: #45
|
2.9 |
—
|
1,886,877 | 22.6% |
P
S
|
10,240,164 | $28,979,664 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ILMN
ILLUMINA INC
|
Healthcare | 0.94% | 1.13% |
#39
4
Prev: #35
|
0.9 |
—
|
-40,458 | -15.0% |
P
S
|
229,215 | $28,253,041 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 0.94% | 1.13% |
#40
4
Prev: #36
|
0.4 |
—
|
-116,700 | -25.7% |
P
S
|
337,559 | $28,115,289 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 0.94% | 1.14% |
#41
7
Prev: #34
|
0.9 |
—
|
-104,500 | -17.4% |
P
S
|
497,020 | $28,076,660 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.91% | 1.32% |
#42
12
Prev: #30
|
0.9 |
—
|
-433,098 | -19.8% |
P
S
|
1,750,766 | $27,136,873 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 0.90% | — |
#43
Prev: #—
|
3.9 |
—
|
310,628 | — |
NEW
|
310,628 | $27,015,317 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DHR
DANAHER CORP DE...
|
Healthcare | 0.88% | 0.87% |
#44
2
Prev: #46
|
2.4 |
—
|
21,100 | 17.8% |
P
S
|
139,327 | $26,416,399 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.88% | — |
#45
Prev: #—
|
3.9 |
—
|
463,600 | — |
NEW
|
463,600 | $26,323,208 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.87% | 0.62% |
#46
8
Prev: #54
|
0.8 |
—
|
-80,373 | -8.7% |
P
S
|
847,151 | $26,185,437 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NTRA
NATERA INC
|
Healthcare | 0.86% | 0.82% |
#47
1
Prev: #48
|
2.3 |
—
|
17,500 | 15.7% |
P
S
|
129,000 | $25,798,710 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.86% | — |
#48
Prev: #—
|
3.8 |
—
|
1,752,798 | — |
NEW
|
1,752,798 | $25,643,435 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
FULC
FULCRUM THERAPE...
|
Healthcare | 0.80% | 1.11% |
#49
12
Prev: #37
|
0.8 |
—
|
73,700 | 2.4% |
P
S
|
3,134,922 | $24,044,852 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZURA
ZURA BIO LTD
|
Healthcare | 0.79% | 0.53% |
#50
6
Prev: #56
|
2.8 |
—
|
808,600 | 25.4% |
P
S
|
3,988,989 | $23,734,485 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-50 of 104 holdings